Researchers in Michael Sigal's lab at the Max Delbruck Center and Charite - Universitatsmedizin Berlin have discovered the significance of the p53 gene in ulcerative colitis. The work, published in Science Advances, proposes a potential new therapeutic target for preventing illness progressi